The Potential Role of Bortezomib in Combination with Chemotherapy and Radiation in Non–Small-Cell Lung Cancer
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 7, S64-S66
- https://doi.org/10.3816/clc.2005.s.011
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non–Small-Cell Lung CancerThe Annals of Thoracic Surgery, 2004
- The role of the ubiquitin/proteasome system in cellular responses to radiationOncogene, 2003
- Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κBInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low dosesRadiotherapy and Oncology, 2001
- Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolideOncogene, 2000
- Cancer Cell CyclesScience, 1996
- How Proteolysis Drives the Cell CycleScience, 1996
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Multimodality therapy in stage III non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expressionImmunity, 1995